日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/30 | 3,490 | 3,574 | 3,486 | 3,561 | +66 | +1.9% | 229,200 |
| 2025/05/29 | 3,497 | 3,505 | 3,429 | 3,495 | +45 | +1.3% | 262,100 |
| 2025/05/28 | 3,455 | 3,469 | 3,430 | 3,450 | +13 | +0.4% | 123,300 |
| 2025/05/27 | 3,428 | 3,451 | 3,421 | 3,437 | +22 | +0.6% | 99,900 |
| 2025/05/26 | 3,455 | 3,465 | 3,411 | 3,415 | -38 | -1.1% | 123,400 |
| 2025/05/23 | 3,450 | 3,475 | 3,442 | 3,453 | +3 | +0.1% | 111,800 |
| 2025/05/22 | 3,384 | 3,461 | 3,382 | 3,450 | +35 | +1% | 189,100 |
| 2025/05/21 | 3,420 | 3,443 | 3,390 | 3,415 | +14 | +0.4% | 109,100 |
| 2025/05/20 | 3,439 | 3,452 | 3,387 | 3,401 | -6 | -0.2% | 217,100 |
| 2025/05/19 | 3,410 | 3,434 | 3,386 | 3,407 | +11 | +0.3% | 197,300 |
| 2025/05/16 | 3,325 | 3,399 | 3,313 | 3,396 | +84 | +2.5% | 219,200 |
| 2025/05/15 | 3,316 | 3,322 | 3,285 | 3,312 | -39 | -1.2% | 176,200 |
| 2025/05/14 | 3,386 | 3,425 | 3,333 | 3,351 | -90 | -2.6% | 232,000 |
| 2025/05/13 | 3,379 | 3,470 | 3,376 | 3,441 | +157 | +4.8% | 487,600 |
| 2025/05/12 | 3,367 | 3,384 | 3,267 | 3,284 | -79 | -2.3% | 455,400 |
| 2025/05/09 | 3,416 | 3,448 | 3,357 | 3,363 | -51 | -1.5% | 414,800 |
| 2025/05/08 | 3,554 | 3,564 | 3,402 | 3,414 | -70 | -2% | 528,600 |
| 2025/05/07 | 3,713 | 3,761 | 3,470 | 3,484 | -251 | -6.7% | 763,400 |
| 2025/05/02 | 3,706 | 3,760 | 3,688 | 3,735 | +33 | +0.9% | 225,000 |
| 2025/05/01 | 3,676 | 3,727 | 3,661 | 3,702 | +25 | +0.7% | 147,700 |
| 2025/04/30 | 3,675 | 3,700 | 3,639 | 3,677 | +38 | +1% | 111,500 |
| 2025/04/28 | 3,620 | 3,664 | 3,620 | 3,639 | +20 | +0.6% | 128,800 |
| 2025/04/25 | 3,617 | 3,651 | 3,596 | 3,619 | +12 | +0.3% | 88,100 |
| 2025/04/24 | 3,623 | 3,652 | 3,607 | 3,607 | -6 | -0.2% | 109,200 |
| 2025/04/23 | 3,626 | 3,648 | 3,604 | 3,613 | +13 | +0.4% | 150,800 |
| 2025/04/22 | 3,565 | 3,605 | 3,543 | 3,600 | +30 | +0.8% | 108,700 |
| 2025/04/21 | 3,595 | 3,599 | 3,542 | 3,570 | -52 | -1.4% | 141,400 |
| 2025/04/18 | 3,587 | 3,622 | 3,547 | 3,622 | +55 | +1.5% | 97,700 |
| 2025/04/17 | 3,547 | 3,570 | 3,542 | 3,567 | -4 | -0.1% | 109,900 |
| 2025/04/16 | 3,560 | 3,613 | 3,546 | 3,571 | +41 | +1.2% | 180,400 |
| 2025/04/15 | 3,540 | 3,584 | 3,516 | 3,530 | +18 | +0.5% | 106,500 |
| 2025/04/14 | 3,487 | 3,569 | 3,466 | 3,512 | +86 | +2.5% | 193,900 |
| 2025/04/11 | 3,499 | 3,507 | 3,385 | 3,426 | -103 | -2.9% | 220,900 |
| 2025/04/10 | 3,571 | 3,579 | 3,440 | 3,529 | +168 | +5% | 265,300 |
| 2025/04/09 | 3,411 | 3,438 | 3,300 | 3,361 | -44 | -1.3% | 305,500 |
| 2025/04/08 | 3,361 | 3,420 | 3,359 | 3,405 | +114 | +3.5% | 241,800 |
| 2025/04/07 | 3,364 | 3,377 | 3,268 | 3,291 | -213 | -6.1% | 268,700 |
| 2025/04/04 | 3,580 | 3,584 | 3,471 | 3,504 | -76 | -2.1% | 242,400 |
| 2025/04/03 | 3,584 | 3,610 | 3,546 | 3,580 | -101 | -2.7% | 238,000 |
| 2025/04/02 | 3,750 | 3,759 | 3,672 | 3,681 | -79 | -2.1% | 227,700 |
| 2025/04/01 | 3,817 | 3,831 | 3,751 | 3,760 | -42 | -1.1% | 276,400 |
| 2025/03/31 | 3,874 | 3,874 | 3,776 | 3,802 | -124 | -3.2% | 336,300 |
| 2025/03/28 | 3,943 | 3,956 | 3,901 | 3,926 | -96 | -2.4% | 166,500 |
| 2025/03/27 | 3,990 | 4,022 | 3,960 | 4,022 | +47 | +1.2% | 170,600 |
| 2025/03/26 | 4,000 | 4,027 | 3,971 | 3,975 | -54 | -1.3% | 232,300 |
| 2025/03/25 | 4,000 | 4,029 | 3,961 | 4,029 | +49 | +1.2% | 198,900 |
| 2025/03/24 | 4,033 | 4,033 | 3,975 | 3,980 | -55 | -1.4% | 123,100 |
| 2025/03/21 | 4,066 | 4,077 | 4,020 | 4,035 | -37 | -0.9% | 290,600 |
| 2025/03/19 | 4,087 | 4,170 | 4,041 | 4,072 | +43 | +1.1% | 220,900 |
| 2025/03/18 | 4,021 | 4,051 | 4,004 | 4,029 | +29 | +0.7% | 154,400 |
1～
50
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 356,100円 | +8.0% | -15.3% | 3.48% | 10.00倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 76,000円 | -11.0% | +206.6% | 0.00% | 7.55倍 | 1.78倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 341,300円 | +3.8% | -19.9% | 3.98% | 11.16倍 | 0.85倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 175,400円 | +5.0% | +1.5% | 0.00% | 15.00倍 | 3.99倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サンバイオ | 301,500円 | - | - | 0.00% | - | 139.65倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
